Pouchitis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Pouchitis – Drugs In Development, 2024 report and make more profitable business decisions.
Pouchitis is an inflammatory condition that occurs as a complication in patients who underwent restorative proctocolectomy or also defined as a condition resulting after the pouch surgery. Genetic mutations may also result in this condition. Increased stool frequency, strong urge for bowel movement, abdominal pain, and presented with fever, dehydration, malnutrition. There is no specific treatment for pouchitis generally off-label drugs used for treating IBD are considered for the management of this condition. Probiotics and antibiotics as a prophylaxis to prevent secondary infections.
The Pouchitis drugs in development market research report provide comprehensive information on the therapeutics under development for Pouchitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pouchitis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Pouchitis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 10 molecules, with 10 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Pouchitis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Pouchitis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Pouchitis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Avivia BVCosmo Pharmaceuticals NV
ExeGi Pharma LLC
Johnson & Johnson
Morphic Therapeutic Inc
MRM Health NV
Novo Nordisk AS
Puretech Health Plc
Reponex Pharmaceuticals AS
Takeda Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pouchitis reports